Evidence map›Paper›PMID 37560009›Full record

ArticleAJOG global reports2023

Perinatal depression before and during the COVID-19 pandemic in New York City.

Meralis Lantigua-Martinez, Megan E Trostle, Anthony Melendez Torres, Pournami Rajeev, Alyson Dennis, Jenna S Silverstein, Mahino Talib

Abstract read
In one paragraph

Article in AJOG global reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2024
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meralis Lantigua-MartinezDepartment of Obstetrics and Gynecology, NYU Langone Health (Drs Lantigua-Martinez, Melendez Torres, and Talib), New York, NY.
Megan E TrostleDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, NYU Langone Health (Drs Trostle and Silverstein), New York, NY.
Anthony Melendez TorresDepartment of Obstetrics and Gynecology, NYU Langone Health (Drs Lantigua-Martinez, Melendez Torres, and Talib), New York, NY.
Pournami RajeevNYU Grossman School of Medicine (Mses Rajeev and Dennis), New York, NY.
Alyson DennisNYU Grossman School of Medicine (Mses Rajeev and Dennis), New York, NY.
Jenna S SilversteinDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, NYU Langone Health (Drs Trostle and Silverstein), New York, NY.
Mahino TalibDepartment of Obstetrics and Gynecology, NYU Langone Health (Drs Lantigua-Martinez, Melendez Torres, and Talib), New York, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundQuarantining and isolation during previous pandemics have been associated with higher levels of depression symptomatology. Studies in other countries found elevated rates of anxiety and/or depression among pregnant people during the COVID-19 pandemic compared with prepandemic rates. New York City was the initial epicenter of the pandemic in the United States, and the effects of the pandemic on perinatal depression in this population are not well known.

objectiveThis study aimed to evaluate the rates of perinatal depression before and during the COVID-19 pandemic. STUDY

designThis is a single-center retrospective cohort study of patients screened for perinatal depression with the Edinburgh Postnatal Depression Scale at 2 private academic practices in New York City. This screen is done in these practices at the time of the glucose challenge test and at the postpartum visit. Patients aged ≥18 years who completed a screen at a postpartum visit and/or glucose challenge test from February 1, 2019 to July 31, 2019 and from February 1, 2020 to July 31, 2020 were identified, and the 2019 and 2020 groups were compared. The primary outcome was a positive screen, defined as ≥13 and ≥15 for postnatal and prenatal screens, respectively. Secondary outcomes included monthly changes in rates of positive screens and factors associated with perinatal depression. Data were analyzed using Mann-Whitney U test, chi-square, or Fisher exact test, and univariate and multivariate analyses with

resultsA total of 1366 records met the inclusion criteria; 75% of the prepandemic (2019) records were included, as opposed to 65% of pandemic (2020) records due to a lower screen completion rate in the pandemic cohort. The 2020 cohort had a higher proportion of Hispanic patients (

conclusionThere were no differences in the rates of perinatal depression between the periods before and during the COVID-19 pandemic. The rate of perinatal depression in this cohort was below the reported averages in the literature. Fewer women were screened for perinatal depression in 2020, which likely underestimated the prevalence of depression in our cohort. These findings highlight potential gaps in care in a pandemic setting.

Indexed as

Edinburgh Postnatal Depression Scalemental healthpostpartum depressionquarantining

Identifiers

PMID37560009
PMCPMC10407240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.